Cargando…
Lipid Nanoparticles for Short Interfering RNA Delivery
The discovery of RNA interference (RNAi) in mammalian cells has created a new class of therapeutics based on the reversible silencing of specific disease-causing genes. This therapeutic potential depends on the ability to deliver inducers of RNAi, such as short-interfering RNA (siRNA) and micro-RNA...
Autores principales: | Leung, Alex K.K., Tam, Yuen Yi C., Cullis, Pieter R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149983/ https://www.ncbi.nlm.nih.gov/pubmed/25409604 http://dx.doi.org/10.1016/B978-0-12-800148-6.00004-3 |
Ejemplares similares
-
Advances in Lipid Nanoparticles for siRNA Delivery
por: Tam, Yuen Yi C., et al.
Publicado: (2013) -
Lipid nanoparticle delivery of glucagon receptor siRNA improves glucose homeostasis in mouse models of diabetes
por: Neumann, Ursula H., et al.
Publicado: (2017) -
Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA
por: Belliveau, Nathan M, et al.
Publicado: (2012) -
Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles
por: Mui, Barbara L, et al.
Publicado: (2013) -
Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting Cells
por: Basha, Genc, et al.
Publicado: (2011)